annual EBITDA:
-$173.63M-$136.60M(-368.90%)Summary
- As of today (July 1, 2025), SLNO annual EBITDA is -$173.63 million, with the most recent change of -$136.60 million (-368.90%) on December 31, 2024.
- During the last 3 years, SLNO annual EBITDA has fallen by -$143.34 million (-473.12%).
- SLNO annual EBITDA is now -21471.87% below its all-time high of -$804.90 thousand, reached on December 31, 2013.
Performance
SLNO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$42.41M+$7.06M(+14.28%)Summary
- As of today (July 1, 2025), SLNO quarterly EBITDA is -$42.41 million, with the most recent change of +$7.06 million (+14.28%) on March 31, 2025.
- Over the past year, SLNO quarterly EBITDA has dropped by -$19.83 million (-87.80%).
- SLNO quarterly EBITDA is now -2253.44% below its all-time high of $1.97 million, reached on March 31, 2013.
Performance
SLNO quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$193.46M-$19.83M(-11.42%)Summary
- As of today (July 1, 2025), SLNO TTM EBITDA is -$193.46 million, with the most recent change of -$19.83 million (-11.42%) on March 31, 2025.
- Over the past year, SLNO TTM EBITDA has dropped by -$141.53 million (-272.51%).
- SLNO TTM EBITDA is now -9922.80% below its all-time high of $1.97 million, reached on March 31, 2013.
Performance
SLNO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SLNO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -368.9% | -87.8% | -272.5% |
| 3 y3 years | -473.1% | -590.9% | -622.4% |
| 5 y5 years | -717.5% | -416.6% | -589.0% |
SLNO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -685.6% | at low | -805.9% | +46.2% | -775.3% | at low |
| 5 y | 5-year | -717.5% | at low | -805.9% | +46.2% | -775.3% | at low |
| alltime | all time | <-9999.0% | at low | -2253.4% | +46.2% | -9922.8% | at low |
SLNO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$42.41M(-14.3%) | -$193.46M(+11.4%) |
| Dec 2024 | -$173.63M(+368.9%) | -$49.48M(-37.2%) | -$173.63M(+26.9%) |
| Sep 2024 | - | -$78.83M(+246.7%) | -$136.81M(+104.7%) |
| Jun 2024 | - | -$22.74M(+0.7%) | -$66.85M(+28.7%) |
| Mar 2024 | - | -$22.58M(+78.4%) | -$51.93M(+40.2%) |
| Dec 2023 | -$37.03M(+67.5%) | -$12.66M(+42.7%) | -$37.03M(+27.5%) |
| Sep 2023 | - | -$8.87M(+13.4%) | -$29.05M(+12.6%) |
| Jun 2023 | - | -$7.82M(+1.8%) | -$25.79M(+9.1%) |
| Mar 2023 | - | -$7.68M(+64.0%) | -$23.64M(+7.0%) |
| Dec 2022 | -$22.10M(-27.0%) | -$4.68M(-16.6%) | -$22.10M(-5.0%) |
| Sep 2022 | - | -$5.61M(-1.1%) | -$23.26M(-6.6%) |
| Jun 2022 | - | -$5.67M(-7.6%) | -$24.89M(-7.1%) |
| Mar 2022 | - | -$6.14M(+5.2%) | -$26.78M(-11.6%) |
| Dec 2021 | -$30.30M(+1.0%) | -$5.84M(-19.4%) | -$30.30M(-4.7%) |
| Sep 2021 | - | -$7.24M(-4.2%) | -$31.79M(+2.1%) |
| Jun 2021 | - | -$7.56M(-21.7%) | -$31.14M(-1.0%) |
| Mar 2021 | - | -$9.65M(+31.7%) | -$31.44M(+4.8%) |
| Dec 2020 | -$30.00M(+41.2%) | -$7.33M(+11.1%) | -$30.00M(+3.2%) |
| Sep 2020 | - | -$6.59M(-16.1%) | -$29.06M(+3.5%) |
| Jun 2020 | - | -$7.86M(-4.2%) | -$28.08M(+11.6%) |
| Mar 2020 | - | -$8.21M(+28.5%) | -$25.16M(+18.5%) |
| Dec 2019 | -$21.24M(+80.4%) | -$6.39M(+13.8%) | -$21.24M(+18.5%) |
| Sep 2019 | - | -$5.62M(+13.4%) | -$17.92M(+15.9%) |
| Jun 2019 | - | -$4.95M(+15.6%) | -$15.46M(+14.5%) |
| Mar 2019 | - | -$4.28M(+39.6%) | -$13.50M(+14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$11.77M(+4.7%) | -$3.07M(-2.9%) | -$11.77M(-15.9%) |
| Sep 2018 | - | -$3.16M(+5.7%) | -$14.00M(+7.6%) |
| Jun 2018 | - | -$2.99M(+17.0%) | -$13.01M(+3.8%) |
| Mar 2018 | - | -$2.56M(-51.8%) | -$12.54M(+11.6%) |
| Dec 2017 | -$11.24M(+35.3%) | -$5.30M(+143.9%) | -$11.24M(+44.9%) |
| Sep 2017 | - | -$2.17M(-13.7%) | -$7.76M(+2.7%) |
| Jun 2017 | - | -$2.52M(+100.7%) | -$7.55M(+3.4%) |
| Mar 2017 | - | -$1.25M(-30.9%) | -$7.31M(-29.0%) |
| Dec 2016 | -$8.31M(-31.1%) | -$1.82M(-7.8%) | -$10.30M(+36.8%) |
| Sep 2016 | - | -$1.97M(-13.3%) | -$7.53M(-14.7%) |
| Jun 2016 | - | -$2.27M(-46.5%) | -$8.83M(-7.9%) |
| Mar 2016 | - | -$4.24M(-545.5%) | -$9.58M(+23.6%) |
| Dec 2015 | -$12.05M(+32.7%) | $952.50K(-129.2%) | -$7.75M(-46.5%) |
| Sep 2015 | - | -$3.27M(+7.8%) | -$14.49M(+15.5%) |
| Jun 2015 | - | -$3.03M(+25.6%) | -$12.54M(+16.0%) |
| Mar 2015 | - | -$2.41M(-58.3%) | -$10.81M(+22.3%) |
| Dec 2014 | -$9.08M(+1027.9%) | -$5.78M(+339.2%) | -$8.84M(+138.3%) |
| Sep 2014 | - | -$1.32M(+1.3%) | -$3.71M(+9.1%) |
| Jun 2014 | - | -$1.30M(+196.1%) | -$3.40M(+3.3%) |
| Mar 2014 | - | -$439.00K(-32.9%) | -$3.29M(+272.4%) |
| Dec 2013 | -$804.90K(-77.5%) | -$653.90K(-35.1%) | -$884.10K(+284.1%) |
| Sep 2013 | - | -$1.01M(-15.5%) | -$230.20K(-129.6%) |
| Jun 2013 | - | -$1.19M(-160.5%) | $777.10K(-60.5%) |
| Mar 2013 | - | $1.97M | $1.97M |
| Dec 2012 | -$3.57M | - | - |
FAQ
- What is Soleno Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Soleno Therapeutics?
- What is Soleno Therapeutics annual EBITDA year-on-year change?
- What is Soleno Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly EBITDA year-on-year change?
- What is Soleno Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Soleno Therapeutics?
- What is Soleno Therapeutics TTM EBITDA year-on-year change?
What is Soleno Therapeutics annual EBITDA?
The current annual EBITDA of SLNO is -$173.63M
What is the all time high annual EBITDA for Soleno Therapeutics?
Soleno Therapeutics all-time high annual EBITDA is -$804.90K
What is Soleno Therapeutics annual EBITDA year-on-year change?
Over the past year, SLNO annual EBITDA has changed by -$136.60M (-368.90%)
What is Soleno Therapeutics quarterly EBITDA?
The current quarterly EBITDA of SLNO is -$42.41M
What is the all time high quarterly EBITDA for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly EBITDA is $1.97M
What is Soleno Therapeutics quarterly EBITDA year-on-year change?
Over the past year, SLNO quarterly EBITDA has changed by -$19.83M (-87.80%)
What is Soleno Therapeutics TTM EBITDA?
The current TTM EBITDA of SLNO is -$193.46M
What is the all time high TTM EBITDA for Soleno Therapeutics?
Soleno Therapeutics all-time high TTM EBITDA is $1.97M
What is Soleno Therapeutics TTM EBITDA year-on-year change?
Over the past year, SLNO TTM EBITDA has changed by -$141.53M (-272.51%)